Sonendo Revenue and Competitors

Location

$271.7M

Total Funding

Estimated Revenue & Valuation

  • Sonendo's estimated annual revenue is currently $32M per year.(i)
  • Sonendo received $50.0M in venture funding in September 2017.
  • Sonendo's estimated revenue per employee is $165,699
  • Sonendo's total funding is $271.7M.
  • Sonendo's current valuation is $215.2M. (January 2022)

Employee Data

  • Sonendo has 193 Employees.(i)
  • Sonendo grew their employee count by 19% last year.

Sonendo's People

NameTitleEmail/Phone
1
Chief Financial OfficerReveal Email/Phone
2
Chief Commercial OfficerReveal Email/Phone
3
VP MarketingReveal Email/Phone
4
VP - Special MarketsReveal Email/Phone
5
VP Human ResourcesReveal Email/Phone
6
VP Sales North AmericaReveal Email/Phone
7
VP, R&DReveal Email/Phone
8
VP Regulatory Affairs Quality AssuranceReveal Email/Phone
9
VP Finance, ControllerReveal Email/Phone
10
Sr. Director, ManufacturingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Sonendo?

Sonendo, Inc. is a privately held, venture-backed company developing innovative technologies to Save Teeth Through Sound Science®. Sonendo's Multisonic Ultracleaning technology is elevating the level of clean throughout endodontics and dentistry. By introducing broad spectrum acoustic technology, Sonendo is helping to reduce doctors reliance on standard instrumentation while saving teeth¹ and changing patients lives. After years of research and development, Sonendo's GentleWave® System presents an entirely new way of thinking about root canal therapy. Using closed-loop, Multisonic Ultracleaning technology, the GentleWave System reaches deep into the lateral canals and microscopic tubules of the root canal system to remove tissue, debris, biofilm and bacteria.² ³ Your practice can offer unprecedented cleaning with the GentleWave System. Sonendo investors include CVF, LLC, DiNovA Capital, Fjord Ventures, Meritech Capital Partners, NeoMed Management, OrbiMed Advisors LLC, SEB Private Equity, and Themes Investment Partners.

keywords:Biotechnology,Enterprise Software,Healthcare,Human Resources Hr,Medical Devices,Pharmaceuticals

$271.7M

Total Funding

193

Number of Employees

$32M

Revenue (est)

19%

Employee Growth %

$215.2M

Valuation

N/A

Accelerator

Sonendo News

2022-04-19 - Sonendo, Inc. (NYSE:SONX) Given Average Rating of “Buy ...

Sonendo logo Sonendo, Inc. (NYSE:SONX – Get Rating) has received a consensus rating of “Buy” from the six brokerages that are presently...

2022-04-17 - Sonendo Announces Launch of CleanFlow Technology

Sonendo, Inc. (NYSE: SONX), a leading dental technology company and developer of the GentleWave System, today announced the launch of its...

2022-04-17 - Sonendo Announces Launch of CleanFlow™ Technology to ...

Sonendo Announces Launch of CleanFlow™ Technology to Improve Doctor and Patient Experience. New Procedure Instrument for GentleWave® System...

2021-11-16 - Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing

LAGUNA HILLS, Calif., Nov. 16, 2021 /PRNewswire/ -- Sonendo, Inc., (NYSE: SONX) a leading dental technology company and developer of the GentleWave® System, today announced the appointment of Alma Salazar as its Associate Vice President, Professional and Consumer Marketing. In her role, Salazar ...

2020-12-16 - Sonendo® Launches 500K Club Charitable Initiative

After Reaching 500,000 GentleWave Patient Milestone, Sonendo Celebrates by Introducing Charitable Initiative LAGUNA HILLS, Calif., Dec. 16, 2020 /PRNewswire/ -- Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, announced today the launch of its "500K ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$40.4M210-5%N/A
#2
$78.4M264-1%N/A
#3
$50.6M27920%N/A
#4
$88.6M2939%N/A
#5
$87.3M2948%N/A

Sonendo Funding

DateAmountRoundLead InvestorsReference
2012-06-29$20.0MUndisclosedOrbiMed Advisors LLCArticle
2013-06-26$18.0MUndisclosedOrbiMed Advisors LLCArticle
2014-01-20$3.1MCArticle
2014-03-25$10.0MUndisclosedOxford FinanceArticle
2014-09-09$35.0MUndisclosedMeritech Capital PartnersArticle
2016-06-03$33.3MUndisclosedMultipleArticle
2016-12-13$35.0MUndisclosedDiNovA CapitalArticle
2017-09-19$50.0MUndisclosedGeneral AtlanticArticle